Endologix to Present at Two Upcoming Conferences
November 08 2011 - 4:15PM
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of minimally
invasive treatments for aortic disorders, announced today that John
McDermott, President and Chief Executive Officer, is scheduled to
present at two upcoming investor conferences. The first
presentation will be at the Stephens Fall Investment Conference in
New York.
Event: |
Stephens Fall Investment Conference |
Date: |
Tuesday, November 15, 2011 |
Time: |
11:30 a.m. ET |
The second presentation will be at the Lazard Capital Markets
8th Annual Healthcare Conference in New York.
Event: |
Lazard Capital Markets 8th Annual Healthcare
Conference |
Date: |
Wednesday, November 16, 2011 |
Time: |
11:00 a.m. ET |
An audio webcast of the Company's presentations will be
available by visiting the investor relations section of Endologix's
website at www.endologix.com. A replay of the presentations will be
available for 30 days.
About Endologix, Inc.
Endologix, Inc. develops and manufactures minimally invasive
treatments for aortic disorders. The Company's focus is
endovascular stent grafts for the treatment of abdominal aortic
aneurysms (AAA). AAA is a weakening of the wall of the aorta, the
largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it a leading cause of death in the U.S. Additional
information can be found on Endologix's website at
www.endologix.com.
CONTACT: COMPANY CONTACT:
Endologix, Inc.
John McDermott, CEO
(949) 595-7200
www.endologix.com
INVESTOR CONTACTS:
The Ruth Group
Nick Laudico
(646) 536-7030
Zack Kubow
(646) 536-7020
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024